| Literature DB >> 23184734 |
Matthias G J Baud1, Patricia Haus, Thomas Leiser, Franz-Josef Meyer-Almes, Matthew J Fuchter.
Abstract
Novel picolinamide-based histone deacetylase (HDAC) inhibitors were developed, drawing inspiration from the natural product psammaplin A. We found that the HDAC potency and isoform selectivity provided by the oxime unit of psammaplin A could be reproduced by using carefully chosen heterocyclic frameworks. The resulting (hetero)aromatic amide based compounds displayed very high potency and isoform selectivity among the HDAC family, in addition to excellent ligand efficiency relative to previously reported HDAC inhibitors. In particular, the high HDAC1 isoform selectivity provided by the chloropyridine motif represents a valuable design criterion for the development of new lead compounds and chemical probes that target HDAC1.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23184734 DOI: 10.1002/cmdc.201200450
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466